Trials / Unknown
UnknownNCT05613361
The Effect of Curcumin Against Colistin-induced Nephrotoxicity
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 214 (estimated)
- Sponsor
- October 6 University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.
Detailed description
The study will investigate the possible nephroprotective effect of curcumin when added to patients infected by MDR Gram-negative bacteria and require intravenous colistin therapy, curcumin will be given concurrently with colistin and discontinued at the same time as Colistin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colistin | added for infection with multi drug resistant bacteria |
| DRUG | Curcumin | added for the possible nephroprotective effect |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-04-30
- Completion
- 2024-10-30
- First posted
- 2022-11-14
- Last updated
- 2023-10-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05613361. Inclusion in this directory is not an endorsement.